- Filed
- Nov 22, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2021 · Nov 19, 2021 | 20.28M sh |
| Cash And Equivalents | Q3 2021 · Sep 30, 2021 | $638.99K |
| Cash And Equivalents | Q3 2021 · Dec 31, 2020 | $932.1K |
| Stockholders Equity | Q3 2021 · Sep 30, 2021 | −$972.12K |
| Stockholders Equity | Q3 2021 · Dec 31, 2020 | −$1.12M |
| Stockholders Equity | Q3 2021 · Sep 30, 2020 | −$806.46K |
| Stockholders Equity | Q3 2021 · Dec 31, 2019 | −$741.68K |
| Current Liabilities | Q3 2021 · Sep 30, 2021 | $10.5M |
| Current Liabilities | Q3 2021 · Dec 31, 2020 | $2.36M |
| Total Liabilities | Q3 2021 · Sep 30, 2021 | $11.2M |
| Total Liabilities | Q3 2021 · Dec 31, 2020 | $3.24M |
| Current Assets | Q3 2021 · Sep 30, 2021 | $9.98M |
| Current Assets | Q3 2021 · Dec 31, 2020 | $1.8M |
| Total Assets | Q3 2021 · Sep 30, 2021 | $10.23M |
| Total Assets | Q3 2021 · Dec 31, 2020 | $2.12M |
| Sga Expense | Q3 2021 · Sep 30, 2021 | $239.09K |
| Sga Expense | Q3 2021 · Sep 30, 2021 | $690.77K |
| Sga Expense | Q3 2021 · Sep 30, 2020 | $206.25K |
| Sga Expense | Q3 2021 · Sep 30, 2020 | $398.63K |
| Shares Diluted | Q3 2021 · Sep 30, 2020 | 20.28M sh |
| Operating Cash Flow | Q3 2021 · Sep 30, 2020 | $351.4K |
| Eps Diluted restated | Q3 2021 · Sep 30, 2020 | $0.00 |
| Net Income | Q3 2021 · Sep 30, 2020 | $28.07K |
| Net Income | Q3 2021 · Sep 30, 2020 | −$57.67K |
| Operating Income | Q3 2021 · Sep 30, 2020 | $42.85K |
| Operating Income | Q3 2021 · Sep 30, 2020 | −$114.53K |
| Gross Profit | Q3 2021 · Sep 30, 2020 | $249.1K |
| Gross Profit | Q3 2021 · Sep 30, 2020 | $284.11K |
| Cost Of Revenue | Q3 2021 · Sep 30, 2020 | $29.89K |
| Cost Of Revenue | Q3 2021 · Sep 30, 2020 | $198.02K |
| Revenue | Q3 2021 · Sep 30, 2020 | $278.99K |
| Revenue | Q3 2021 · Sep 30, 2020 | $482.13K |